We are live on
!
Find out more
Alyeska Investment Group Portfolio holdings
AUM
$35.4B
1-Year Est. Return
33.54%
This Fund
S&P 500
This Quarter
Est. Return
+8.66%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$19.6B
AUM Growth
+$2.1B
(+12%)
Cap. Flow
+$943M
Cap. Flow
% of AUM
4.81%
Top 10 Holdings %
Top 10 Hldgs %
14.75%
Holding
739
New
183
Increased
150
Reduced
140
Closed
230
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$314M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$235M |
| 3 |
lululemon athletica
LULU
|
+$221M |
| 4 |
Home Depot
HD
|
+$217M |
| 5 |
Analog Devices
ADI
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$263M |
| 2 |
TE Connectivity
TEL
|
+$242M |
| 3 |
Zoom
ZM
|
+$242M |
| 4 |
Qualcomm
QCOM
|
+$208M |
| 5 |
Meta Platforms (Facebook)
META
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.88% |
| 2 | Consumer Discretionary | 18.76% |
| 3 | Healthcare | 12.63% |
| 4 | Industrials | 12.54% |
| 5 | Financials | 8.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Cognition Therapeutics
CGTX
$94M
| $234K | ﹤0.01% |
500,000
| – | – |
|
502
Kyverna Therapeutics
KYTX
$480M
| $220K | ﹤0.01% |
45,000
-45,000
| -50% | -$347K |
|
503
American Tower
AMT
$78.8B
| $207K | ﹤0.01% |
+890
| New | +$197K |
|
|
EXAS
504
DELISTED
Exact Sciences
EXAS
| $206K | ﹤0.01% |
+3,027
| New | +$171K |
|
505
IN8bio
INAB
$9.61M
| $117K | ﹤0.01% |
14,494
-6,873
| -32% | -$124K |
|
|
GAUZ
506
Gauzy
GAUZ
$7.5M
| $90.7K | ﹤0.01% |
10,250
-35,855
| -78% | -$365K |
|
507
Torrid Holdings
CURV
$249M
| $63.5K | ﹤0.01% |
+16,159
| New | +$109K |
|
508
SunPower Inc
SPWR
$49.6M
| $37.6K | ﹤0.01% |
+13,369
| New | +$24.3K |
|
|
509
Apple
AAPL
$4.5T
| – | – |
-1,250,528
| Closed | -$263M |
|
510
CALL
Abeona Therapeutics
ABEO
$425M
| – | – |
-70,000
| Closed | -$297K |
|
|
ABX
511
CALL
Abacus Global Management
ABX
$913M
| – | – |
-140,219
| Closed | -$1.21M |
|
|
ACB
512
CALL
Aurora Cannabis
ACB
$179M
| – | – |
-820,000
| Closed | -$3.79M |
|
513
Accenture
ACN
$109B
| – | – |
-47,037
| Closed | -$14.3M |
|
514
Adtran
ADTN
$622M
| – | – |
-570,066
| Closed | -$3M |
|
515
Addus HomeCare
ADUS
$2.23B
| – | – |
-30,000
| Closed | -$3.48M |
|
516
CALL
Advantage Solutions
ADV
$383M
| – | – |
-19,547
| Closed | -$1.57M |
|
|
AEVA
517
CALL
Aeva Technologies
AEVA
$1.65B
| – | – |
-300,000
| Closed | -$756K |
|
518
American International
AIG
$40.7B
| – | – |
-166,419
| Closed | -$12.4M |
|
519
Aligos Therapeutics
ALGS
$47.8M
| – | – |
-11,369
| Closed | -$99.5K |
|
520
Alaska Air
ALK
$5.27B
| – | – |
-109,686
| Closed | -$4.43M |
|
|
ALUR
521
CALL
DELISTED
Allurion Technologies
ALUR
| – | – |
-3,915
| Closed | -$97.6K |
|
522
CALL
Alvotech
ALVO
$1.28B
| – | – |
-100,000
| Closed | -$1.22M |
|
523
CALL
Ardagh Metal Packaging
AMBP
$2.97B
| – | – |
-60,159
| Closed | -$205K |
|
524
AN2 Therapeutics
ANTX
$213M
| – | – |
-100,000
| Closed | -$215K |
|
525
APi Group
APG
$18.3B
| – | – |
-469,433
| Closed | -$11.8M |
|
Similar funds
SAM
VIA
Alyeska Investment Group's Q3 2024 Portfolio in Review
As of Q3 2024, Alyeska Investment Group held 739 positions worth $19.6B, up 12% from $17.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Alyeska Investment Group deployed $943M of net new capital in Q3 2024, opening 183 new positions and adding to 150 existing holdings. Its largest new stake was Microsoft: 734,107 shares worth $316M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Zoom, an estimated $242M trimmed.
- Alyeska Investment Group's largest Q3 2024 buy was Microsoft: 734,107 shares worth $316M.
- Alyeska Investment Group added most to lululemon athletica in Q3 2024, an estimated $221M increase.
- Alyeska Investment Group's biggest Q3 2024 reduction was Zoom, cutting an estimated $242M.
- Alyeska Investment Group fully exited Apple in Q3 2024, selling an estimated $263M.
- Alyeska Investment Group's ten largest holdings make up 15% of its $19.6B portfolio in Q3 2024.
- Alyeska Investment Group opened 183 new positions and closed 230 in Q3 2024.
- Alyeska Investment Group's portfolio value rose 12% quarter-over-quarter to $19.6B.
Based on Alyeska Investment Group's 13F filing for Q3 2024, filed 14 Nov 2024.